Syngene International Limited has informed the Exchange regarding a press release dated January 22, 2026, titled "Nine months revenue from operations up 3% year-on-year to Rs. 2,702 Cr - Third quarter revenue from operations down 3% year-on-year to Rs. 917 Cr".
Press Release Jan 22 2026
Earlier from Syngene International
- Syngene International extends long-term research collaboration with Bristol Myers Squibb until 2035
- Press Release Jan 19 2026
- Press Release Nov 05 2025
- Syngene International announces plans to add bioconjugation suite for end-to-end Antibody-Drug Conjugates Development